The expansion was driven by lower priced items, including diabetic drugs and vitamins. “During the quarter under review, the ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

The mutual fund expert believes that a strategic allocation of 10-20% in the pharma and healthcare funds could benefit ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

Companies that manufacture diagnostics, technology and equipment to address the world’s most pressing medical issues have ...

John Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue ...

The government's new Rs 500 crore scheme for the medical device industry will not only boost domestic manufacturing but also ...

South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...